# Maximus, Inc.: Form 10-Q for the period ended Dec 31, 2014

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2015-02-06
- Accepted by EDGAR: Feb 6, 2015, 21:03 ET
- Period: 2014-12-31
- Accession: 0001104659-15-007433
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000110465915007433/a14-26490_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000110465915007433/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-10-01 to 2014-12-31 | $467.0m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2014-10-01 to 2014-12-31 | $347.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2014-10-01 to 2014-12-31 | $119.3m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2014-10-01 to 2014-12-31 | $54.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-10-01 to 2014-12-31 | $65.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2014-10-01 to 2014-12-31 | $23.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-10-01 to 2014-12-31 | $41.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-10-01 to 2014-12-31 | $0.63 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-10-01 to 2014-12-31 | $0.63 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-10-01 to 2014-12-31 | 66,898,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2014-10-01 to 2014-12-31 | $56.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2014-10-01 to 2014-12-31 | $12.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2014-10-01 to 2014-12-31 | $3.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2014-10-01 to 2014-12-31 | $32.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-12-31 | $149.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-12-31 | $523.5m | us-gaap:AssetsCurrent |
| Total assets | at 2014-12-31 | $892.3m | us-gaap:Assets |
| Current liabilities | at 2014-12-31 | $254.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-12-31 | $333.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2014-12-31 | $557.7m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 14,766 characters.

*The following discussion and analysis of financial condition and results of operations is provided to enhance the understanding of, and should be read in conjunction with, our Consolidated Financial Statements and related Notes included both herein and in our Annual Report on Form 10-K for the year ended September 30, 2014, filed with the Securities and Exchange Commission on November 17, 2014.*

### Business Overview

We provide business process services (BPS) to government health and human services agencies under our mission of *Helping Government Serve the People.®* We are one of the largest pure-play health and human services BPS providers to governments in the United States, Australia, Canada, the United Kingdom and Saudi Arabia. We use our experience, business process management expertise and advanced technological solutions to help government agencies run efficient and cost-effective programs, improve program accountability and outcomes and enhance the quality of services provided to program beneficiaries.

Over the past five years, our business has grown significantly. We believe this growth has been driven by economic and demographic factors, such as aging populations and increased demand for health care, and the need for governments to operate programs effectively and efficiently. This growth has been driven by reform efforts in the United States, including the Affordable Care Act, as well as internationally with various welfare-to-work programs in Australia and the United Kingdom’s Work Programme.

We believe that governments will continue to seek opportunities to enhance existing processes or address new challenges through companies such as MAXIMUS. We believe that a combination of our innovative technical solutions, deep subject matter expertise, stringent adherence to our Standards of Business Conduct and Ethics, robust financial performance and global experience gives existing and future customers the confidence that MAXIMUS can reliably operate their high-profile public health and human services programs.

### Results of Operations

#### Consolidated

The following table sets forth, for the periods indicated, selected statements of operations data:

*(dollars in thousands, except per share data)*

|  | Three Months Ended December 31, 2014 | 2013 |
| --- | ---: | ---: |
| Revenue | $467,043 | $406,592 |
| Gross profit | $119,267 | $105,916 |
| Gross profit percentage | 25.5% | 26.0% |
| Selling, general and administrative expenses | $54,036 | $52,619 |
| Selling, general and administrative expenses as a percentage of revenue | 11.6% | 12.9% |
| Operating income | $65,231 | $53,297 |
| Operating income margin | 14.0% | 13.1% |
| Interest and other income, net | 901 | 332 |
| Income before income taxes | $66,132 | $53,629 |
| Provision for income taxes | 23,782 | 20,274 |
| Effective tax rate | 36.0% | 37.8% |
| Net income | 42,350 | 33,355 |
| (Income)/loss attributable to noncontrolling interests | (489) | 504 |
| Net income attributable to MAXIMUS | $41,861 | $33,859 |
| Basic earnings per share | $0.63 | $0.50 |
| Diluted earnings per share | $0.63 | $0.49 |

The following provides an overview of the significant elements of our Consolidated Statements of Operations. As our business segments have different factors driving revenue growth and profitability, the sections that follow cover these segments in greater detail.

Revenue, gross profit and operating profit have all increased for the three months ended December 31, 2014, compared to the prior-year period, by 15%, 13% and 22%, respectively. This growth was across both segments and was entirely organic revenue, driven by new work and the expansion of existing contracts. We were adversely affected by the effects of foreign currency fluctuations with the strengthening of the United States Dollar reducing revenues and profits in our foreign operations, particularly within our Human Services Segment.

Our interest income has received the benefit of interest income from higher cash balances in jurisdictions outside the United States, which have higher rates, as well as foreign exchange benefits in this quarter.

Our effective tax rate for the three months ended December 31, 2014 was 36.0%. We are anticipating an effective rate of 36.7% for the full year. During the first quarter of fiscal year 2015, we received a benefit from the retroactive provision of the United States Work Opportunity Tax Credit through the beginning of calendar year 2014. This resulted in a reduction to our tax charge of $0.6 million.

#### Health Services Segment

The Health Services Segment provides a variety of business process services, as well as related consulting services, for state, provincial and national government programs, including Medicaid, CHIP, Supplemental Nutrition Assistance Program (SNAP), Medicare, the Affordable Care Act (ACA) and Health Insurance BC (British Columbia). This segment also includes the operations of two significant United Kingdom contracts which are in start-up and are expected to commence revenue-generating activities in our second fiscal quarter.

*(dollars in thousands)*

|  | Three Months Ended December 31, 2014 | 2013 |
| --- | ---: | ---: |
| Revenue | $351,667 | $299,158 |
| Gross profit | 85,566 | 76,818 |
| Operating income | 50,357 | 41,553 |
| Gross profit percentage | 24.3% | 25.7% |
| Operating margin percentage | 14.3% | 13.9% |

Revenue for the three months ended December 31, 2014 increased 18% compared to the same period in fiscal year 2014. Operating income increased by 21%. Revenue for the current year period benefitted from new work as well as expansion of existing contracts including expected accretive change orders. These benefits have been offset by anticipated declines in income in our federal Medicare appeals business and anticipated start-up losses in a new federal contract, which have also reduced gross profit margins. Overall operating profit margins have grown as selling, general and administrative costs have remained stable.

Our first fiscal quarter benefits from additional work through the open enrollment period for the Affordable Care Act which, in fiscal year 2015, runs from November 1, 2014 through February 15, 2015. As open enrollment drives additional revenue-generating activity, we anticipate that this segment will experience seasonal growth during the first quarter of each fiscal year.

This segment is anticipated to receive the benefit of revenue from two new contracts commencing in the United Kingdom during the second fiscal quarter of the year, tempered by further start-up costs.

#### Human Services Segment

The Human Services Segment provides national, state and county human services agencies with a variety of business process services and related consulting services for welfare-to-work, child support, higher education and K-12 special education programs.

*(dollars in thousands)*

|  | Three Months Ended December 31, 2014 | 2013 |
| --- | ---: | ---: |
| Revenue | $115,376 | $107,434 |
| Gross profit | 33,701 | 29,098 |
| Operating income | 15,479 | 11,760 |
| Gross profit percentage | 29.2% | 27.1% |
| Operating margin percentage | 13.4% | 10.9% |

The Human Services Segment has received the benefit of new work and the timing of contract extensions within our international welfare-to-work businesses. The contract extensions resulted in approximately $2.4 million of incremental revenue and profit in the period. This has been offset by the detrimental effects of foreign exchange rates, which reduced revenue by approximately $5.0 million.

### Liquidity and Capital Resources

Our principal source of liquidity remains cash flows from operations. We use these cash flows to fund working capital and capital expenditures, acquire businesses, repurchase our own common shares and pay dividends. Cash collections from customers are driven by a number of factors. For many contracts, particularly those in our Human Services Segment, customer payments may be based upon our success at delivering outcomes and, accordingly, our cash inflows will not correspond with the related cash outflows. Customer payments may also be subject to delays. These most often occur at the beginning of a contract as processes for billing and review and processing are being established. We have also experienced short-term payment delays from customers where budget constraints have occurred. We were not significantly affected by the shut-down of the U.S. Federal Government in early fiscal year 2014 but, in the event of a more protracted delay, it is possible that our cash flows, operations and profitability could be affected. Our operating cash outflows will also be affected by our contract life-cycle. At the beginning of contracts, we will typically incur one-time capital expenses and the costs of commencing a contract, as well as increasing the required levels of working capital that we will need.

We hold significant cash balances and have access to additional funds. At December 31, 2014, we held $149.2 million of cash and cash equivalents and had access to up to $95.3 million from a revolving credit facility. At December 31, 2014, our foreign subsidiaries held approximately $180 million of cumulative earnings. We have no requirement or intent to remit these earnings to the United States. We consider undistributed earnings of our foreign subsidiaries to be indefinitely reinvested outside of the United States and, accordingly, no U.S. deferred taxes have been recorded with respect to such earnings in accordance with the relevant accounting guidance for income taxes. Should the earnings be remitted as dividends, we may be subject to additional U.S. taxes, net of allowable foreign tax credits. It is not practicable to estimate the amount of any additional taxes which may be payable on the undistributed earnings given the various tax planning alternatives we could employ should we decide to repatriate these earnings in a tax-efficient manner. As of December 31, 2014, our foreign subsidiaries held approximately 30% of our cash and cash equivalents.

#### Cash Flows

*(dollars in thousands)*

| Net cash provided by (used in): | Three Months Ended December 31, 2014 | 2013 |
| --- | ---: | ---: |
| Operating activities | $56,594 | $41,946 |
| Investing activities | (13,950) | (7,909) |
| Financing activities | (47,954) | (37,134) |
| Effect of exchange rate changes on cash and cash equivalents | (3,606) | (1,936) |
| Net decrease in cash and cash equivalents | $(8,916) | $(5,033) |

Cash provided by operating activities have increased 35% to $56.6 million for the three months ended December 31, 2014, compared with the period in the prior fiscal year. This increase was driven by the growth of our business and improvements in our cash collections.

Cash used in investing activities was $14.0 million for the three months ended December 31, 2014, compared to $7.9 million for the three months ended December 31, 2013. The increase is principally driven by investment in the United Kingdom related to two projects which are set to start in our second fiscal quarter.

Although many of the start-up costs to be incurred by the United Kingdom contracts will be reimbursed, we anticipate that our cash flows may be tempered in the remaining quarters of this fiscal year as payments are made for milestones achieved in the start-up of these contracts. We believe we have sufficient funds available to cover this cash outflow.

Cash used in financing activities was $48.0 million and $37.1 million for the three months ended December 31, 2014 and 2013, respectively. The increase was driven by $32.6 million of repurchases of common stock in fiscal year 2015, compared to $21.5 million of repurchases in fiscal year 2014.

To supplement our statements of cash flows presented on a GAAP basis, we use the non-GAAP measure of free cash flows to analyze the funds generated from operations. We believe free cash flow is a useful basis for comparing our performance with our competitors. The presentation of non-GAAP free cash flows is not meant to be considered in isolation, nor as an alternative to net income as an indicator of performance, nor as an alternative to cash flows from operating activities as a measure of liquidity. In addition, this non-GAAP financial measure, as determined and presented by us, may not be comparable to other related or similarly titled measures used by other companies. We calculate free cash flow as follows:

*(dollars in thousands)*

|  | Three Months Ended December 31, 2014 | 2013 |
| --- | ---: | ---: |
| Cash provided by operating activities | $56,594 | $41,946 |
| Purchases of property and equipment | (12,754) | (4,440) |
| Capitalized software costs | (1,356) | (3,584) |
| Free cash flow | $42,484 | $33,922 |

### Critical Accounting Policies and Estimates

Our discussion and analysis of financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenue and expenses. On an ongoing basis, we evaluate our estimates including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill and other long-lived assets, and amounts related to contingencies and income tax liabilities. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

We believe that we do not have material off-balance-sheet risk or exposure to liabilities that are not recorded or disclosed in our financial statements. While we have significant operating lease commitments for office space, those commitments are generally tied to the period of performance under related contracts. Additionally, although on certain contracts we are bound by performance bond commitments and standby letters of credit, we have not had any defaults resulting in draws on performance bonds. Also, we do not speculate in derivative transactions.

During the three months ended December 31, 2014, there were no significant changes to the critical accounting policies we disclosed in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the year ended September 30, 2014.

## Market risk

As filed, 407 characters.

We believe that our exposure to market risk related to the effect of changes in interest rates, foreign currency exchange rates, commodity prices and other market risks with regard to instruments entered into for trading or for other purposes is immaterial.

There have been no material changes in the information presented in Item 7A of our Annual Report on Form 10-K for the year ended September 30, 2014.

## Controls and procedures

As filed, 1,545 characters.

(a) Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 434 characters.

In connection with information set forth in this Form 10-Q, the factors discussed under “Risk Factors” in our Form 10-K for fiscal year ended September 30, 2014 should be considered. The risks included in the Form 10-K could materially and adversely affect our business, financial condition and results of operations. There have been no material changes to the factors discussed in our Form 10-K for the year ended September 30, 2014.

Filed Feb 6, 2015.
Source: SEC EDGAR, the filing index for accession 0001104659-15-007433. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
